Home » ACT Seeks FDA OK for Stem Cell Study to Treat Blindness
ACT Seeks FDA OK for Stem Cell Study to Treat Blindness
Worcester-based biotech Advanced Cell Technology [ACT] Inc. has filed an investigational new drug application to use human embryonic stem cells to treat
an untreatable disease that is the most common cause of juvenile blindness.
Mass High Tech
Mass High Tech
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May